Mineralys Therapeutics, Inc.'s total assets for Q4 2025 were $661.81M, an increase of 10.31% from the previous quarter. MLYS total liabilities were $15.11M for the fiscal quarter, a -35.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.